Description
A TLR8 agonist; increases the production of TNF-α and IL-12 in human PBMCs (EC50s = 140 and 120 nM, respectively), monocytes, and dendritic cells; increases cytolysis in K562 NK cell-sensitive leukemia cells at 167 and 500 nM for 48 hours; increases plasma levels of a group of human cytokines , including IL-6, IL-12p70, TNF-α, MCP-1, and MIP-1β, in NSG-HIS mice at 1.5 and 15 mg/m2; reduces tumor growth and increases tumor infiltration of monocytes and T cells in an ovarian cancer NSG-HIS mouse model
Formal name: 2-amino-N,N-dipropyl-8-[4-(1-pyrrolidinylcarbonyl)phenyl]-3H-1-benzazepine-4-carboxamide
Synonyms: VTX-2337
Molecular weight: 458.6
CAS: 926927-61-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Immunology & Inflammation|Adaptive Immunity||Research Area|Immunology & Inflammation|Innate Immunity|Pattern Recognition